on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Life Science REIT plc
The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its stake in Life Science REIT plc. As of February 12, 2026, Vanguard holds 3,263,889 units, representing a 0.93% stake in the company, as per their announcement on February 13, 2026. This disclosure also involves British Land Company plc.
The filing details Vanguard's interests in 1p ordinary securities but does not report any cash-settled or stock-settled derivative positions. Vanguard recently purchased 4,212 shares at 0.43 GBP each. No indemnity or other dealing arrangements are present, and there are no supplemental open position forms attached.
Vanguard clarified that no agreements or understandings concerning options or derivatives exist with any other parties.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news